Invesco S&P 500 Equal Weight Health Care ETF
Invesco S&P 500 Equal Weight Health Care ETF reported 59 holdings worth US$767M as of Jul 31, 2026 (Form N-PORT)
As of Jul 31, 2026 · Filed Sep 28, 2026
Invesco S&P 500 Equal Weight Health Care ETF reported 59 holdings worth US$767M as of Jul 31, 2026. Largest: Bio-techne Corp, Iqvia Holdings, Inc. and Baxter International Inc. Filed Sep 28, 2026 (Form N-PORT).
- Holdings
- 59
- Value as reported
- US$767M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Bio-techne Corp | 226K | US$16.3M | 2.1% |
| Iqvia Holdings, Inc. | 65,238 | US$15.3M | 2.0% |
| Baxter International Inc. | 584K | US$15.3M | 2.0% |
| Regeneron Pharmaceuticals, Inc. | 19,739 | US$15.1M | 2.0% |
| Mettler-toledo International, Inc. | 10,518 | US$14.9M | 1.9% |
| Charles River Laboratories International, Inc. | 63,739 | US$14.8M | 1.9% |
| Veeva Systems Inc. | 72,510 | US$14.8M | 1.9% |
| Davita Inc. | 59,771 | US$14.4M | 1.9% |
| Moderna, Inc. | 258K | US$14.1M | 1.8% |
| Thermo Fisher Scientific Inc | 24,599 | US$14.1M | 1.8% |
| Abbott Laboratories | 133K | US$14.1M | 1.8% |
| Bristol-myers Squibb Company | 214K | US$13.9M | 1.8% |
| Universal Health Services, Inc. | 81,941 | US$13.8M | 1.8% |
| Labcorp Holdings Inc. | 44,184 | US$13.7M | 1.8% |
| Quest Diagnostics Incorporated | 58,185 | US$13.6M | 1.8% |
| Amgen Inc. | 35,158 | US$13.5M | 1.8% |
| Incyte Corporation | 113K | US$13.5M | 1.8% |
| Becton, Dickinson And Company | 80,253 | US$13.3M | 1.7% |
| Dexcom, Inc. | 159K | US$13.2M | 1.7% |
| Abbvie Inc. | 52,782 | US$13.2M | 1.7% |
| Viatris Inc. | 753K | US$13.2M | 1.7% |
| Revvity, Inc. | 117K | US$13.2M | 1.7% |
| Cencora, Inc. | 42,185 | US$13.1M | 1.7% |
| Steris Plc (ireland) | 57,066 | US$13M | 1.7% |
| Insulet Corporation | 78,813 | US$13M | 1.7% |
| Merck & Company, Inc. | 99,646 | US$13M | 1.7% |
| Vertex Pharmaceuticals Incorporated | 27,186 | US$13M | 1.7% |
| Resmed Inc. | 61,357 | US$12.9M | 1.7% |
| Henry Schein, Inc. | 151K | US$12.9M | 1.7% |
| Mckesson Corporation | 15,050 | US$12.9M | 1.7% |
| Johnson & Johnson | 49,845 | US$12.8M | 1.7% |
| Hca Healthcare, Inc. | 31,727 | US$12.8M | 1.7% |
| Gilead Sciences, Inc. | 97,666 | US$12.7M | 1.7% |
| The Cooper Companies, Inc. | 175K | US$12.7M | 1.7% |
| Ge Healthcare Technologies Inc. | 186K | US$12.7M | 1.7% |
| Cvs Health Corporation | 121K | US$12.6M | 1.6% |
| Zimmer Biomet Holdings, Inc. | 135K | US$12.6M | 1.6% |
| Medtronic Plc. | 148K | US$12.6M | 1.6% |
| Cardinal Health, Inc. | 54,900 | US$12.6M | 1.6% |
| Danaher Corporation | 64,594 | US$12.6M | 1.6% |
| Solventum Corporation | 147K | US$12.5M | 1.6% |
| Stryker Corporation | 38,366 | US$12.5M | 1.6% |
| Agilent Technologies, Inc. | 90,207 | US$12.5M | 1.6% |
| Biogen Inc. | 61,162 | US$12.4M | 1.6% |
| Waters Corporation | 32,715 | US$12.3M | 1.6% |
| West Pharmaceutical Services, Inc. | 35,828 | US$12.2M | 1.6% |
| Unitedhealth Group Incorporated | 29,098 | US$12.1M | 1.6% |
| Eli Lilly And Company | 10,490 | US$12.1M | 1.6% |
| Idexx Laboratories, Inc. | 21,369 | US$11.9M | 1.6% |
| Edwards Lifesciences Corporation | 138K | US$11.9M | 1.6% |
| Humana Inc. | 32,609 | US$11.9M | 1.5% |
| Align Technology, Inc. | 69,694 | US$11.8M | 1.5% |
| Pfizer, Inc. | 464K | US$11.6M | 1.5% |
| Boston Scientific Corporation | 246K | US$11.5M | 1.5% |
| Centene Corporation | 182K | US$11.3M | 1.5% |
| Zoetis Inc. | 146K | US$11.3M | 1.5% |
| The Cigna Group | 40,098 | US$11.2M | 1.5% |
| Elevance Health, Inc. | 29,292 | US$11M | 1.4% |
| Intuitive Surgical, Inc. | 28,801 | US$10.2M | 1.3% |
Source
View original at SEC
Related